MAF Antibody

中文名稱：

MAF兔多克隆抗體
貨號：

CSB-PA013312LA01HU
規格：

￥440
圖片：
Immunohistochemistry of paraffin-embedded human small intestine tissue using CSB-PA013312LA01HU at dilution of 1:100
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) MAF Polyclonal antibody
Uniprot No.：

O75444
基因名：

MAF
別名：

AS42 oncogene homolog antibody; Avian musculoaponeurotic fibrosarcoma (MAF) protooncogene antibody; Avian musculoaponeurotic fibrosarcoma (v maf) antibody; c maf proto oncogene antibody; cMaf antibody; maf antibody; MAF_HUMAN antibody; MAF2 antibody; MGC71685 antibody; Proto oncogene c Maf antibody; Proto-oncogene c-maf antibody; Transcription factor Maf antibody; v maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) antibody; v maf musculoaponeurotic fibrosarcoma oncogene homolog antibody; V-maf musculoaponeurotic fibrosarcoma oncogene homolog antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Transcription factor Maf protein (55-180AA)
免疫原種屬：

Homo sapiens (Human)

標記方式：

Non-conjugated

本頁面中的產品，MAF Antibody (CSB-PA013312LA01HU)，的標記方式是Non-conjugated。對于MAF Antibody，我們還提供其他標記。見下表：

標記方式	貨號	產品名稱	應用
HRP	CSB-PA013312LB01HU	MAF Antibody, HRP conjugated	ELISA
FITC	CSB-PA013312LC01HU	MAF Antibody, FITC conjugated
Biotin	CSB-PA013312LD01HU	MAF Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產品提供形式：

Liquid
應用范圍：

ELISA, IHC

推薦稀釋比：

Application	Recommended Dilution
IHC	1:20-1:200

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Acts as a transcriptional activator or repressor. Involved in embryonic lens fiber cell development. Recruits the transcriptional coactivators CREBBP and/or EP300 to crystallin promoters leading to up-regulation of crystallin gene during lens fiber cell differentiation. Activates the expression of IL4 in T helper 2 (Th2) cells. Increases T-cell susceptibility to apoptosis by interacting with MYB and decreasing BCL2 expression. Together with PAX6, transactivates strongly the glucagon gene promoter through the G1 element. Activates transcription of the CD13 proximal promoter in endothelial cells. Represses transcription of the CD13 promoter in early stages of myelopoiesis by affecting the ETS1 and MYB cooperative interaction. Involved in the initial chondrocyte terminal differentiation and the disappearance of hypertrophic chondrocytes during endochondral bone development. Binds to the sequence 5'-[GT]G[GC]N[GT]NCTCAGNN-3' in the L7 promoter. Binds to the T-MARE (Maf response element) sites of lens-specific alpha- and beta-crystallin gene promoters. Binds element G1 on the glucagon promoter. Binds an AT-rich region adjacent to the TGC motif (atypical Maf response element) in the CD13 proximal promoter in endothelial cells. When overexpressed, represses anti-oxidant response element (ARE)-mediated transcription. Involved either as an oncogene or as a tumor suppressor, depending on the cell context. Binds to the ARE sites of detoxifying enzyme gene promoters.
基因功能參考文獻：
1. common variant , rs889472, of c-MAF is associated with gout susceptibility. PMID: 29080939
2. we identified two heterozygous rare variants in genes that are involved in early cataract development; the novel c.809C>A; p.(Ser270Tyr) in MAF and the c.168C>G; p.(Tyr56 *) variant in CRYGD, previously reported as pathogenic PMID: 28849415
3. UBE2O mediates c-Maf polyubiquitination and degradation, induces MM cell apoptosis, and suppresses myeloma tumor growth, which provides a novel insight in understanding myelomagenesis and UBE2O biology. PMID: 28673317
4. The interaction between c-Maf and RORgammat, and Blimp-1. PMID: 28300844
5. Polymorphisms rs9939609 (FTO gene) and rs1424233 (MAF gene) were genotyped using allelic discrimination assays in a prospective multicenter cohort study; these polymorphisms did not show associations with birth weight, BMI and Ponderal Index at discharge, and weight gain, neither testing for a dominant, additive nor for a recessive model. PMID: 23840443
6. this study shows that genes associated with MAF-binding enhancers are suppressed in macrophages isolated from rheumatoid-arthritis patients, revealing a disease-associated signature of IFN-gamma-mediated repression PMID: 28813657
7. Our results argued that increased expression of sIL6R from myeloid cells and subsequent c-Maf induction were adverse events for counteracting tumor-specific Th1 generation. Overall, this work provides a mechanistic rationale for sIL6R targeting to improve the efficacy of T-cell-mediated cancer immunotherapy PMID: 28235765
8. These results define the role of MAF and GSK3 in the resistance of t(14;16) multiple myeloma to proteasome inhibitors. PMID: 27793878
9. interplay between MATalpha1, c-Myc, and Maf proteins, and their deregulation during chronic cholestasis may facilitate cholangiocarcinoma oncogenesis PMID: 26969892
10. Epidermal differentiation gene regulatory networks are controlled by MAF and MAFB. PMID: 27097296
11. Findings implicate the strong effects of ROS on multiple stem cell functions with a central role for c-Maf in stem cell senescence. PMID: 26496036
12. Collectively, these studies show that FGF signaling up-regulates expression of alphaA-crystallin both directly and indirectly via up-regulation of c-Maf. PMID: 26719333
13. Results suggest that MAF is a mediator of breast cancer bone metastasis. 16q23 gain or MAF protein overexpression in tumors may help to select patients at risk of bone relapse. PMID: 26376684
14. Differential effect of cataract-associated mutations in MAF on transactivation of MAF target crystalline genes. PMID: 25064449
15. Study added a novel insight for c-MAF ubiquitination and degradation, suggesting that c-MAF stability is strictly regulated. PMID: 25448412
16. Disease-causing mutations were demonstrated to impair proper MAF phosphorylation, ubiquitination and proteasomal degradation, perturbed gene expression in primary skin fibroblasts, and induced neurodevelopmental defects in an in vivo model. PMID: 25865493
17. MAF has a role in mediating crosstalk between Ras-MAPK and mTOR signaling in NF1 PMID: 24509877
18. LPS promotes PDCD4 degradation via a pathway involving PI3K and mTOR, releasing Twist2, which induces IL-10 via c-Maf. PMID: 24982420
19. Results imply a regulatory role for TMEM18, BDNF, MTCH2 and NEGR1 in adipocyte differentiation and biology. In addition, we show a variation of MAF expression during adipogenesis, while NPC1, PTER and SH2B1 were not regulated. PMID: 23229156
20. c-Maf increases human immunodeficiency virus (HIV)-1 expression in interleukin (IL)-4-producing CD4 T cells by binding the proximal HIV-1 long terminal repeat region (LTR) and augmenting HIV-1 transcription. PMID: 22875803
21. Bcl6 and Maf collaborate to orchestrate a suite of genes that define core characteristics of human Tfh cell biology. PMID: 22427637
22. findings show that the transcription factor c-Maf/c-MAF is crucial for mechanosensory function; sensitivity to high-frequency vibration is reduced in humans carrying a dominant mutation in the c-MAF gene PMID: 22345400
23. we studied the mechanisms underlying IL-2 regulation of C-MAF expression in human T cells PMID: 21876034
24. Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins. PMID: 21216956
25. the MEK-ERK pathway regulates MAF transcription PMID: 21163924
26. Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein PMID: 21362551
27. Monocyte-derived macrophages with CD14 of high-antigen positivity display increased expression of c-Maf, which upregulates production of two key factors (hyaluronan and interleukin-10) that promote growth of Mycobacterium tuberculosis. PMID: 21209279
28. c-Maf interacts with Ubc9 & PIAS1. c-Maf can be SUMOylated at Lys-33 in vitro. SUMOylation attenuates its transcriptional activity. PMID: 20127678
29. Taken together, these studies demonstrate a new level of transcriptional regulation of MMP-13 expression by the c-maf. PMID: 20067416
30. novel role for MAF as a transcriptional repressor, preventing expression of blood vessel endothelial cells-specific genes, thereby maintaining the differentiation status of lymphatic endothelial cells PMID: 20080955
31. results suggest that Tc-mip plays a critical role in Th2 signaling pathway and represents the first proximal signaling protein which links TCR-mediated signal to the activation of c-maf Th2 specific factor PMID: 12939343
32. The short form of the proto-oncogene c-maf is highly induced in minimal change nephrotic syndrome T cells during relapse, where it translocates to the nuclear compartment and binds to the DNA responsive element. PMID: 14688382
33. High levels of c-maf mRNA is associated with multiple myeloma PMID: 14692531
34. c-maf transforms plasma cells by stimulating cell cycle progression and by altering bone marrow stromal interactions PMID: 14998494
35. role of c-Maf in the transcriptional regulation of IL-10 and the underlying molecular mechanism in macrophages PMID: 15749884
36. results suggest that c-Maf might cause a type of T-cell lymphoma in both mice and humans and that ARK5, in addition to cyclin D2 and integrin beta(7), might be downstream target genes of c-Maf leading to malignant transformation PMID: 16424013
37. Findings expand the mutation spectrum of MAF in association with congenital cataract and highlight the genetic and phenotypic heterogeneity of congenital cataract. PMID: 16470690
38. Segmental allergen challenge in asthmatics leads to increased GATA-3, c-maf and T-bet expression in BAL cells but not in bronchial biopsies PMID: 16498264
39. OPN is significantly upregulated in MM patients with maf translocations, particularly in the fraction lacking bone disease PMID: 17044113
40. c-Maf is capable of interactions with c-Myb that lead to reduced promoter binding and decreased Bcl-2 expression, rendering CD4 T cells more prone to apoptosis. PMID: 17823980
41. the differential DNA binding specificity between Maf homodimers and Nrf2-Maf heterodimers establishes the differential gene regulation by these dimer-forming transcription factors PMID: 17875642
42. CD13 transcription is regulatd by MAF via an atypical response element. PMID: 17897790
43. Pax-6 and c-Maf interact with G1 to activate basal expression of the glucagon gene PMID: 17901057
44. MAF mutation p.Arg299Ser is the third mutation identified in association with the CCMC phenotype, and all three mutations are located in the basic region of the DNA binding domain in the MAF protein (OMIM 177075). PMID: 17982426
45. Angioimmunoblastic T-cell lymphoma(AILT) shows c-Maf expression and provide new insight into the pathogenesis of AILT suggesting c-Maf to be a useful diagnostic marker. PMID: 18059226
46. MafG-mediated nuclear retention may enable Nrf2 proteins to evade cytosolic proteasomal degradation and consequently stabilize Nrf2 signaling PMID: 18585411
47. The exclusion of these genes as likely candidates supports the hypothesis that the ocular phenotype associated with peters' anomaly segregating in this family is a distinct, new, autosomal dominant entity in the anterior segment dysgenesis spectrum. PMID: 18616618
48. In addition to FTO and MC4R, we detected significant association of obesity with three new risk loci in NPC1 (endosomal/lysosomal Niemann-Pick C1 gene), near MAF (encoding the transcription factor c-MAF) and near PTER (phosphotriesterase-related gene). PMID: 19151714
49. c-maf may be important in chondrocyte hypertrophy and terminal differentiation, and may be involved in the pathogenesis of osteoarthritis PMID: 19215682
50. detection of c-Maf may be of particular value in the differential diagnosis of small cell lymphomas. PMID: 19687312
顯示更多

收起更多
相關疾病：

Cataract 21, multiple types (CTRCT21); Ayme-Gripp syndrome (AYGRP)
亞細胞定位：

Nucleus.
蛋白家族：

BZIP family, Maf subfamily
組織特異性：

Expressed in endothelial cells.
數據庫鏈接：

HGNC: 6776

OMIM: 177075

KEGG: hsa:4094

STRING: 9606.ENSP00000327048

UniGene: Hs.134859

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
VDAC1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human, Mouse, Rat